SARASOTA, Fla.--(BUSINESS WIRE)--Mar. 12, 2009-- Aetna (NYSE: AET) announced today that it has signed a three-year agreement with Intercoastal Medical Group Inc. Under the new contract, members of Aetna’s Medicare Advantage HMO and PPO plans, will be able to receive covered benefits, at in-network rates, from Intercoastal Medical Group physicians. The contract takes effect April 1.
Intercoastal Medical Group already provides in-network care to members of Aetna’s commercial health plans in the Tampa-area.
“Aetna is very pleased to expand its relationship with Intercoastal Medical Group,” said Jim McCunney, Aetna’s vice president of network management for the Tampa area. “Members of our commercial plans have been receiving excellent care from Intercoastal physicians for some time, and we’re glad that our present and future Medicare Advantage members will be able to benefit from the same services.”
Aetna is the only Medicare Advantage insurer presently contracted with Intercoastal.
“We are very pleased to be able to offer this association with Aetna to our patients and to be the care providers for Intercoastal Aetna patients,” said Geoff Simon, Intercoastal Medical Group administrator.
About Intercoastal Medical Group
Founded in 1993, Intercoastal Medical Group (IMG) is a professional association of more than 60 board-certified physicians encompassing 18 specialties. IMG's seven locations in Sarasota and Manatee counties include physician offices, laboratories, imaging facilities and a day surgery center.
Aetna provides health benefits to approximately 437,000 members in the Tampa area. Those members have access to a network that includes 60 contracted hospitals and more than 7,000 primary care physicians and specialists.
Showing posts with label Club21. Show all posts
Showing posts with label Club21. Show all posts
Thursday, March 12, 2009
Tuesday, March 10, 2009
Aetna Consumer-Directed Health Care Works!
Aetna Announces Results of a Six-Year Study of Consumer-Directed Health Plans
-- Aetna HealthFund(R) Shows Sustained Savings Over Time For Employers, With Members Getting the Care They Need --
HARTFORD, Conn.--(BUSINESS WIRE)--Mar. 10, 2009-- Aetna (NYSE: AET) today announced the results of a six-year study of health care claims and utilization for members in its Aetna HealthFund® consumer-directed plans. The study of 2.6 million Aetna members (410,000 in an Aetna HealthFund plan) demonstrates that Aetna HealthFund shows sustained savings for employers over a five-year period, with members getting the care they need. The results also show that Aetna HealthFund members are seeking increased levels of chronic and preventive care, using generic drugs more often and accessing online tools and information at higher rates than PPO members, while experiencing lower annualized medical cost increases. Importantly, this year’s results also show that Aetna HealthFund members had lower emergency room use than PPO members, suggesting that members are becoming better informed about where to access health care.
The Aetna HealthFund study included 200 plan sponsors who offered an Aetna HealthFund Health Reimbursement Arrangement (HRA) and/or an Aetna HealthFund Health Savings Account (HSA). The study looked at 2.6 million members across the spectrum of Aetna medical products, including 410,000 Aetna HealthFund members. Key findings include:
For full replacement HRA and HSA plans, employers saved $21 million per 10,000 members over the five year period.
For employers who offer Aetna HealthFund plans as an option, they experienced savings of $7 million per 10,000 members over the five year period.
For employers who offer Aetna HealthFund plans as an option and implemented the strategies that Aetna identified as best-in-class, they achieved savings of $23 million per 10,000 members over the five year period.
“In these difficult economic times, employers are looking for tried and true strategies that will allow them to continue to offer their employees a comprehensive and affordable benefits package,” said Aetna President Mark Bertolini. “As the first national health plan to offer consumer-directed products, Aetna has the longest experience with these plans and the best insight into what strategies are successful.”
Last year, Aetna identified several strategies that have proven successful for employers, including fostering a culture where employees and senior executives are engaged health care consumers, implementing a focused and ongoing employee education campaign, offering wellness programs and incentives for healthy behavior, providing 100 percent coverage for preventive care and carefully constructing a plan with the right mix of member responsibility. While these strategies continue to be successful, Aetna found another approach that can help employers achieve success - encouraging their employees to enroll in the consumer-directed plan option. This can be done by offering the consumer-directed plan option as the lowest cost, lowering the required contribution or increasing the fund amount. Furthermore, this year’s results show that employers who implement these strategies can achieve significant cost savings and that more employers are adopting these strategies and seeing positive results.
“Consumerism in health care is about much more than a product – it is the idea that with the right mix of education, member responsibility and benefits design, you can engage members and help them make more informed health care decisions for themselves and their families. In fact, this year’s results show that consumers in the Aetna HealthFund plans sought online health information twice as often as the control population and were twice as likely to take a health risk assessment,” Bertolini added.
The results also show that Aetna HealthFund members:
Seek preventive care more often than the control matched PPO population. Furthermore, Aetna HealthFund members had 10 percent lower primary care physician utilization for non-routine services and 15 percent lower utilization of specialist care.
Access the same or higher levels of screenings for diabetes and breast and cervical cancer, compared to members in traditional PPO products.
Utilize the prescription drugs necessary to treat chronic conditions such as diabetes, congestive heart failure, coronary artery disease and high cholesterol at similar or higher rates than PPO members.
Use consumer tools and information – including searching for health information, using the cost of care tools available through Aetna Navigator – at twice the rate compared to PPO members.
“Aetna’s analysis of members in its Aetna HealthFund plans exemplifies the importance of providing credible data that will help employers evaluate the performance of these plans. It is always a challenge to adopt new ideas, particularly in the face of a recession,” said Alexander Domaszewicz, Mercer’s Health Consumerism Lead. “The study reinforces the evidence we’ve seen emerge throughout the decade - that strategies such as encouraging employee financial responsibility, offering robust coverage for preventive care and providing a full suite of online tools and information, is helping employers achieve cost savings, promote a healthier workforce and still meet plan sponsor attraction, retention and employee satisfaction goals. We need to recognize, however, that many employees need high touch outreach and face-to-face support when they face complex illnesses. The ideal strategy when implementing consumer-directed health plans combines all of these approaches in the right way.”
-- Aetna HealthFund(R) Shows Sustained Savings Over Time For Employers, With Members Getting the Care They Need --
HARTFORD, Conn.--(BUSINESS WIRE)--Mar. 10, 2009-- Aetna (NYSE: AET) today announced the results of a six-year study of health care claims and utilization for members in its Aetna HealthFund® consumer-directed plans. The study of 2.6 million Aetna members (410,000 in an Aetna HealthFund plan) demonstrates that Aetna HealthFund shows sustained savings for employers over a five-year period, with members getting the care they need. The results also show that Aetna HealthFund members are seeking increased levels of chronic and preventive care, using generic drugs more often and accessing online tools and information at higher rates than PPO members, while experiencing lower annualized medical cost increases. Importantly, this year’s results also show that Aetna HealthFund members had lower emergency room use than PPO members, suggesting that members are becoming better informed about where to access health care.
The Aetna HealthFund study included 200 plan sponsors who offered an Aetna HealthFund Health Reimbursement Arrangement (HRA) and/or an Aetna HealthFund Health Savings Account (HSA). The study looked at 2.6 million members across the spectrum of Aetna medical products, including 410,000 Aetna HealthFund members. Key findings include:
For full replacement HRA and HSA plans, employers saved $21 million per 10,000 members over the five year period.
For employers who offer Aetna HealthFund plans as an option, they experienced savings of $7 million per 10,000 members over the five year period.
For employers who offer Aetna HealthFund plans as an option and implemented the strategies that Aetna identified as best-in-class, they achieved savings of $23 million per 10,000 members over the five year period.
“In these difficult economic times, employers are looking for tried and true strategies that will allow them to continue to offer their employees a comprehensive and affordable benefits package,” said Aetna President Mark Bertolini. “As the first national health plan to offer consumer-directed products, Aetna has the longest experience with these plans and the best insight into what strategies are successful.”
Last year, Aetna identified several strategies that have proven successful for employers, including fostering a culture where employees and senior executives are engaged health care consumers, implementing a focused and ongoing employee education campaign, offering wellness programs and incentives for healthy behavior, providing 100 percent coverage for preventive care and carefully constructing a plan with the right mix of member responsibility. While these strategies continue to be successful, Aetna found another approach that can help employers achieve success - encouraging their employees to enroll in the consumer-directed plan option. This can be done by offering the consumer-directed plan option as the lowest cost, lowering the required contribution or increasing the fund amount. Furthermore, this year’s results show that employers who implement these strategies can achieve significant cost savings and that more employers are adopting these strategies and seeing positive results.
“Consumerism in health care is about much more than a product – it is the idea that with the right mix of education, member responsibility and benefits design, you can engage members and help them make more informed health care decisions for themselves and their families. In fact, this year’s results show that consumers in the Aetna HealthFund plans sought online health information twice as often as the control population and were twice as likely to take a health risk assessment,” Bertolini added.
The results also show that Aetna HealthFund members:
Seek preventive care more often than the control matched PPO population. Furthermore, Aetna HealthFund members had 10 percent lower primary care physician utilization for non-routine services and 15 percent lower utilization of specialist care.
Access the same or higher levels of screenings for diabetes and breast and cervical cancer, compared to members in traditional PPO products.
Utilize the prescription drugs necessary to treat chronic conditions such as diabetes, congestive heart failure, coronary artery disease and high cholesterol at similar or higher rates than PPO members.
Use consumer tools and information – including searching for health information, using the cost of care tools available through Aetna Navigator – at twice the rate compared to PPO members.
“Aetna’s analysis of members in its Aetna HealthFund plans exemplifies the importance of providing credible data that will help employers evaluate the performance of these plans. It is always a challenge to adopt new ideas, particularly in the face of a recession,” said Alexander Domaszewicz, Mercer’s Health Consumerism Lead. “The study reinforces the evidence we’ve seen emerge throughout the decade - that strategies such as encouraging employee financial responsibility, offering robust coverage for preventive care and providing a full suite of online tools and information, is helping employers achieve cost savings, promote a healthier workforce and still meet plan sponsor attraction, retention and employee satisfaction goals. We need to recognize, however, that many employees need high touch outreach and face-to-face support when they face complex illnesses. The ideal strategy when implementing consumer-directed health plans combines all of these approaches in the right way.”
Monday, March 2, 2009
GE Cuts Dividend
FAIRFIELD, Conn.--(BUSINESS WIRE)--The Board of Directors of General Electric Company (NYSE:GE) today authorized a plan to reduce the Company’s quarterly dividend to $0.10 from $0.31 per outstanding share of the Company's common stock, effective for the second half of 2009. This decision will preserve approximately $9 billion for the Company on an annualized basis.
Merck Announces 2nd Quarter Dividend
Merck Announces Second-Quarter 2009 Dividend
WHITEHOUSE STATION, N.J., Feb. 24, 2009 - The Board of Directors of Merck & Co., Inc., meeting today, declared a quarterly dividend of $0.38 per share on the Company's common stock for the second quarter of 2009. The $0.38 per share dividend is payable on April 1, 2009 to stockholders of record at the close of business on March 6, 2009.
WHITEHOUSE STATION, N.J., Feb. 24, 2009 - The Board of Directors of Merck & Co., Inc., meeting today, declared a quarterly dividend of $0.38 per share on the Company's common stock for the second quarter of 2009. The $0.38 per share dividend is payable on April 1, 2009 to stockholders of record at the close of business on March 6, 2009.
Friday, February 27, 2009
Aetna Continues With Share Repurchase
Aetna Board of Directors Authorizes Additional Share Repurchases
HARTFORD, Conn.--(BUSINESS WIRE)--Feb. 27, 2009-- Aetna Inc. (NYSE: AET) today announced that its Board of Directors has authorized the company to repurchase from time to time up to $750 million of its common stock.
The company intends to continue buying shares in the open market from time to time. At December 31, 2008, Aetna had approximately 456 million shares outstanding.
HARTFORD, Conn.--(BUSINESS WIRE)--Feb. 27, 2009-- Aetna Inc. (NYSE: AET) today announced that its Board of Directors has authorized the company to repurchase from time to time up to $750 million of its common stock.
The company intends to continue buying shares in the open market from time to time. At December 31, 2008, Aetna had approximately 456 million shares outstanding.
Thursday, February 26, 2009
Aetna Adds Four New Adventist Health System Hospitals
Aetna Adds Four New Adventist Health System Hospitals
ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 26, 2009-- Aetna (NYSE: AET) and Adventist Health System announced today that they have reached agreement on a new contract that adds four new Adventist hospitals to Aetna’s provider networks in the Central Florida and Tampa Bay/West Central Florida areas. The new contract took effect last month.
Under the agreement, the following facilities will be joining Aetna’s provider network: Florida Hospital Waterman; Heartland Medical Center; Florida Hospital Lake Placid and Florida Hospital Wauchula.
“We are pleased to be a participating provider for Aetna members at all 18 Florida Hospital locations,” said John Brownlow, senior vice president of managed care at Adventist.
Members of Aetna’s network-based plans will be able to receive covered in-patient and out-patient services, at in-network rates, from all four facilities. The contract also applies to the system’s affiliated physicians.
“Aetna is delighted to announce the addition of these four new hospitals,” said Jim McCunney, Aetna’s network vice president for the Central Florida area. “We strive to provide our members with broad access to high-quality hospitals and physicians, and we’re pleased to expand that access in the Central and West Central Florida areas.”
Aetna provides and administers health benefits to more than 625,000 members in Central and West Central Florida. Those members have access to a contracted network of more than 95 hospitals, and more than 13,000 primary care physicians and specialists.
About Florida Hospital
Opened in 1908, Florida Hospital is one of the largest not-for-profit hospitals in the country, caring for more than 1 million patient visits per year – that’s more than any other hospital in the country, according to the American Hospital Association. The more-than-2,000-bed system, comprised of eight hospitals and 18 Centra Care locations, has been recognized by U.S. News & World Report as one of the best hospitals in the country for the past 10 years.
ORLANDO, Fla.--(BUSINESS WIRE)--Feb. 26, 2009-- Aetna (NYSE: AET) and Adventist Health System announced today that they have reached agreement on a new contract that adds four new Adventist hospitals to Aetna’s provider networks in the Central Florida and Tampa Bay/West Central Florida areas. The new contract took effect last month.
Under the agreement, the following facilities will be joining Aetna’s provider network: Florida Hospital Waterman; Heartland Medical Center; Florida Hospital Lake Placid and Florida Hospital Wauchula.
“We are pleased to be a participating provider for Aetna members at all 18 Florida Hospital locations,” said John Brownlow, senior vice president of managed care at Adventist.
Members of Aetna’s network-based plans will be able to receive covered in-patient and out-patient services, at in-network rates, from all four facilities. The contract also applies to the system’s affiliated physicians.
“Aetna is delighted to announce the addition of these four new hospitals,” said Jim McCunney, Aetna’s network vice president for the Central Florida area. “We strive to provide our members with broad access to high-quality hospitals and physicians, and we’re pleased to expand that access in the Central and West Central Florida areas.”
Aetna provides and administers health benefits to more than 625,000 members in Central and West Central Florida. Those members have access to a contracted network of more than 95 hospitals, and more than 13,000 primary care physicians and specialists.
About Florida Hospital
Opened in 1908, Florida Hospital is one of the largest not-for-profit hospitals in the country, caring for more than 1 million patient visits per year – that’s more than any other hospital in the country, according to the American Hospital Association. The more-than-2,000-bed system, comprised of eight hospitals and 18 Centra Care locations, has been recognized by U.S. News & World Report as one of the best hospitals in the country for the past 10 years.
Wednesday, February 18, 2009
Aetna 4th Quarter Earnings
Aetna Reports Fourth-Quarter and Full-Year 2008 Results
HARTFORD, Conn.--(BUSINESS WIRE)--Feb. 12, 2009-- Aetna (NYSE: AET):
>Fourth-quarter 2008 operating earnings per share increased 9 percent to $0.96
>Full-year 2008 operating earnings per share increased 13 percent to $3.93
>Net income per share decreased 52 percent in the fourth quarter 2008 to $0.42 per share and decreased 18 percent to $2.83 per share for the full year. Net income includes net realized capital losses and other items, which are excluded from operating earnings
>Medical membership totaled 17.7 million members at December 31, 2008; representing an annual growth of 848,000 and a quarter-over-quarter growth of 33,000
>Aetna projects 2009 operating earnings per share of $3.85 to $3.95. Excluding a projected $0.54 per share year-over-year increase in pension expense, operating earnings per share growth is projected to be 12 to 14 percent over 2008
Aetna (NYSE: AET) today announced that fourth-quarter 2008 operating earnings per share, (1) which exclude net realized capital losses and other items, increased 9 percent to $0.96. Full-year 2008 operating earnings per share increased 13 percent to $3.93. The increase in operating earnings per share reflects significant growth in revenue, solid underwriting results and continued operating expense efficiencies, partially offset by lower net investment income. Operating results also benefited from share repurchases and the full-year impact of recent acquisitions. The company’s 17 percent growth in full-year health care revenue was driven by premium rate increases and medical membership growth in both core and newer customer segments. Total health care revenue, including realized capital losses, grew by 16 percent for the full year.
Net income, which includes net realized capital losses and other items, was $0.42 per share for the fourth quarter of 2008, 52 percent lower than the prior-year quarter, due to net realized capital losses of $0.42 per share and the previously announced severance and facility charge and contribution for the establishment of a new out-of-network pricing database of $.08 and $.04 per share, respectively. Full-year 2008 net income was $2.83 per share, 18 percent lower than 2007, primarily due to net realized capital losses of $.99 per share. The majority of the net realized capital losses resulted from declines in the market value of debt securities in the company’s investment portfolio as a result of the widening of credit spreads in 2008.
HARTFORD, Conn.--(BUSINESS WIRE)--Feb. 12, 2009-- Aetna (NYSE: AET):
>Fourth-quarter 2008 operating earnings per share increased 9 percent to $0.96
>Full-year 2008 operating earnings per share increased 13 percent to $3.93
>Net income per share decreased 52 percent in the fourth quarter 2008 to $0.42 per share and decreased 18 percent to $2.83 per share for the full year. Net income includes net realized capital losses and other items, which are excluded from operating earnings
>Medical membership totaled 17.7 million members at December 31, 2008; representing an annual growth of 848,000 and a quarter-over-quarter growth of 33,000
>Aetna projects 2009 operating earnings per share of $3.85 to $3.95. Excluding a projected $0.54 per share year-over-year increase in pension expense, operating earnings per share growth is projected to be 12 to 14 percent over 2008
Aetna (NYSE: AET) today announced that fourth-quarter 2008 operating earnings per share, (1) which exclude net realized capital losses and other items, increased 9 percent to $0.96. Full-year 2008 operating earnings per share increased 13 percent to $3.93. The increase in operating earnings per share reflects significant growth in revenue, solid underwriting results and continued operating expense efficiencies, partially offset by lower net investment income. Operating results also benefited from share repurchases and the full-year impact of recent acquisitions. The company’s 17 percent growth in full-year health care revenue was driven by premium rate increases and medical membership growth in both core and newer customer segments. Total health care revenue, including realized capital losses, grew by 16 percent for the full year.
Net income, which includes net realized capital losses and other items, was $0.42 per share for the fourth quarter of 2008, 52 percent lower than the prior-year quarter, due to net realized capital losses of $0.42 per share and the previously announced severance and facility charge and contribution for the establishment of a new out-of-network pricing database of $.08 and $.04 per share, respectively. Full-year 2008 net income was $2.83 per share, 18 percent lower than 2007, primarily due to net realized capital losses of $.99 per share. The majority of the net realized capital losses resulted from declines in the market value of debt securities in the company’s investment portfolio as a result of the widening of credit spreads in 2008.
Aetna Partners With Patient Choice Insights
Aetna Signs Contract with Patient Choice Healthcare, Inc.
ST. LOUIS PARK, Minn.--(BUSINESS WIRE)--Feb. 17, 2009-- Aetna (NYSE: AET), the nation’s third largest insurance company, announced that it will begin offering Patient Choice Insights, a tiered health care provider network in Minnesota.
Patient Choice is recognized as a leader for its tiered network model launched nearly a decade ago. With the Patient Choice Insights network, health care providers are ranked on cost and quality measures and members are encouraged to use providers who rank best in delivering value.
Aetna will offer the Patient Choice Insights network to self-funded employers and their employees in central and southern Minnesota. “This network option allows us to offer new customers a highly competitive network solution, and consequently, greater quality and value to both our employers and their employees,” said Ross Sanders, president of national accounts for Aetna’s north central and southwest regions.
“We can now offer a national solution to both Minnesota-based employers, and national employers with employees in Minnesota, that combines highly regarded transparency and quality tools for members with some of the strongest medical management capabilities in the industry,” he added.
“Now more than ever, employers are looking for ways to reduce costs and having a quality network of participating providers greatly helps achieve that goal. We’re conducting a seminar on February 23 in Minneapolis for brokers, consultants and employers focusing on additional ways we can help them reduce costs,” said Sanders.*
ST. LOUIS PARK, Minn.--(BUSINESS WIRE)--Feb. 17, 2009-- Aetna (NYSE: AET), the nation’s third largest insurance company, announced that it will begin offering Patient Choice Insights, a tiered health care provider network in Minnesota.
Patient Choice is recognized as a leader for its tiered network model launched nearly a decade ago. With the Patient Choice Insights network, health care providers are ranked on cost and quality measures and members are encouraged to use providers who rank best in delivering value.
Aetna will offer the Patient Choice Insights network to self-funded employers and their employees in central and southern Minnesota. “This network option allows us to offer new customers a highly competitive network solution, and consequently, greater quality and value to both our employers and their employees,” said Ross Sanders, president of national accounts for Aetna’s north central and southwest regions.
“We can now offer a national solution to both Minnesota-based employers, and national employers with employees in Minnesota, that combines highly regarded transparency and quality tools for members with some of the strongest medical management capabilities in the industry,” he added.
“Now more than ever, employers are looking for ways to reduce costs and having a quality network of participating providers greatly helps achieve that goal. We’re conducting a seminar on February 23 in Minneapolis for brokers, consultants and employers focusing on additional ways we can help them reduce costs,” said Sanders.*
Tuesday, February 10, 2009
GE Declares Quarterly Dividend
GE Board of Directors Authorizes Regular Quarterly Dividend
Friday, February 06, 2009, 2:54:00 PM
FAIRFIELD, Conn.--(BUSINESS WIRE)--The Board of Directors of General Electric Company (NYSE:GE) today authorized a regular quarterly dividend of $0.31 per outstanding share of the Company’s common stock. The dividend is payable April 27, 2009, to shareowners of record at the close of business on February 23, 2009. The ex-dividend date is February 19, 2009. This dividend payment will complete the dividend for the first half of 2009.
Friday, February 06, 2009, 2:54:00 PM
FAIRFIELD, Conn.--(BUSINESS WIRE)--The Board of Directors of General Electric Company (NYSE:GE) today authorized a regular quarterly dividend of $0.31 per outstanding share of the Company’s common stock. The dividend is payable April 27, 2009, to shareowners of record at the close of business on February 23, 2009. The ex-dividend date is February 19, 2009. This dividend payment will complete the dividend for the first half of 2009.
Tuesday, February 3, 2009
Merck 4th Quarter 2008 Earnings Beats The Street
Merck Announces Fourth-Quarter and Full-Year 2008 Financial Results
>Company Announces Fourth-Quarter 2008 Non-GAAP EPS of $0.87, Excluding 9 Cents of Restructuring Charges; Fourth-Quarter GAAP EPS of $0.78
>Merck Reports Full-Year 2008 Non-GAAP EPS of $3.42, Excluding Certain Items; Full-Year GAAP EPS of $3.64
>Strong Performance of Newer Products, JANUVIA, JANUMET, ROTATEQ and ISENTRESS, Continued During 2008
>Merck Reaffirms Full-Year 2009 Non-GAAP EPS Range of $3.15 to $3.30, Excluding Certain Items; Reaffirms 2009 GAAP EPS Range of $2.95 to $3.17
WHITEHOUSE STATION, N.J., Feb. 3, 2009 - Merck & Co., Inc. today announced financial results for the fourth-quarter and full-year of 2008.
The Company reported fourth-quarter 2008 non-GAAP (generally accepted accounting principles) earnings per share (EPS) of $0.87, which excludes restructuring charges of $0.09. Fourth-quarter GAAP EPS was $0.78. Merck also announced full-year 2008 non-GAAP EPS of $3.42, excluding certain items, and full-year GAAP EPS of $3.64.
For the fourth quarter of 2008, worldwide sales were $6.0 billion, a decrease of 3 percent over the fourth quarter of 2007. Worldwide sales were $23.9 billion for full-year 2008, a decrease of 1 percent over full year 2007. Foreign exchange provided an unfavorable effect to global sales performance of 1 percent for the quarter and a favorable effect of 3 percent for the year.
Net income for the fourth quarter was $1,644.8 million, compared with a net loss of $1,630.9 million in the fourth quarter of 2007. Merck reported $7,808.4 million in net income for full-year 2008, compared with $3,275.4 million in the full year of 2007. Fourth-quarter 2007 net loss and full-year 2007 net income reflect a $4.85 billion pretax charge related to the U.S. VIOXX Settlement Agreement. Full-year 2008 net income includes a $2.2 billion pretax gain on a distribution from AstraZeneca LP.
>Company Announces Fourth-Quarter 2008 Non-GAAP EPS of $0.87, Excluding 9 Cents of Restructuring Charges; Fourth-Quarter GAAP EPS of $0.78
>Merck Reports Full-Year 2008 Non-GAAP EPS of $3.42, Excluding Certain Items; Full-Year GAAP EPS of $3.64
>Strong Performance of Newer Products, JANUVIA, JANUMET, ROTATEQ and ISENTRESS, Continued During 2008
>Merck Reaffirms Full-Year 2009 Non-GAAP EPS Range of $3.15 to $3.30, Excluding Certain Items; Reaffirms 2009 GAAP EPS Range of $2.95 to $3.17
WHITEHOUSE STATION, N.J., Feb. 3, 2009 - Merck & Co., Inc. today announced financial results for the fourth-quarter and full-year of 2008.
The Company reported fourth-quarter 2008 non-GAAP (generally accepted accounting principles) earnings per share (EPS) of $0.87, which excludes restructuring charges of $0.09. Fourth-quarter GAAP EPS was $0.78. Merck also announced full-year 2008 non-GAAP EPS of $3.42, excluding certain items, and full-year GAAP EPS of $3.64.
For the fourth quarter of 2008, worldwide sales were $6.0 billion, a decrease of 3 percent over the fourth quarter of 2007. Worldwide sales were $23.9 billion for full-year 2008, a decrease of 1 percent over full year 2007. Foreign exchange provided an unfavorable effect to global sales performance of 1 percent for the quarter and a favorable effect of 3 percent for the year.
Net income for the fourth quarter was $1,644.8 million, compared with a net loss of $1,630.9 million in the fourth quarter of 2007. Merck reported $7,808.4 million in net income for full-year 2008, compared with $3,275.4 million in the full year of 2007. Fourth-quarter 2007 net loss and full-year 2007 net income reflect a $4.85 billion pretax charge related to the U.S. VIOXX Settlement Agreement. Full-year 2008 net income includes a $2.2 billion pretax gain on a distribution from AstraZeneca LP.
Wednesday, January 28, 2009
AT&T 4th Quarter 2008 Earnings
AT&T Reports Fourth-Quarter and Full-Year Results Highlighted by Robust Wireless Data Growth, Accelerated U-verse TV Ramp, Continued Double-Digit Growth in IP Data Services
Dallas, Texas, January 28, 2009
>Full-year reported EPS of $2.16, up from $1.94 for 2007; full-year adjusted EPS of $2.81, compared with $2.76 for 2007
>Fourth-quarter reported EPS of $0.41 versus $0.51 for the year-earlier quarter; adjusted fourth-quarter EPS of $0.64 versus $0.71
>Fourth-quarter EPS reflects the success of AT&T's iPhone 3G launch. Adjusted results exclude merger-related costs and a previously announced force reduction charge. In addition, both reported and adjusted fourth-quarter 2008 earnings include $0.07 of pressure from the company's iPhone 3G initiative, hurricane-related expenses and foreign exchange impacts
>2.1 million fourth-quarter net gain in wireless subscribers to reach 77.0 million in service, up 7.0 million over the past year
>4.3 million iPhone 3G devices activated in the second half of 2008, including 1.9 million in the fourth quarter. Approximately 40 percent of iPhone activations were for customers new to AT&T. iPhone 3G continues to deliver high-value subscribers with significantly higher ARPU (average monthly revenues per subscriber) and lower churn than AT&T's postpaid subscriber average
>Wireless postpaid subscriber ARPU growth of 3.9 percent versus the year-earlier quarter to $59.59; postpaid data ARPU up 35.7 percent versus the fourth quarter of 2007 and up 10.9 percent sequentially
>51.2 percent growth in wireless data revenues — reflecting rapid adoption of wireless integrated devices and increased usage of wireless Internet access, messaging and related services; AT&T's wireless integrated devices in service more than doubled over the past year
>Strong ramp in AT&T U-verseSM TV subscribers, with a fourth-quarter net increase of 264,000, the company's best quarterly gain to date, to reach more than 1 million in service; U-verse network deployment now reaches 17 million living units
>14.2 percent fourth-quarter growth in wireline IP data revenues driven by rapid expansion in AT&T U-verse services and growth in business products such as Virtual Private Networks (VPNs) and managed Internet services
Dallas, Texas, January 28, 2009
>Full-year reported EPS of $2.16, up from $1.94 for 2007; full-year adjusted EPS of $2.81, compared with $2.76 for 2007
>Fourth-quarter reported EPS of $0.41 versus $0.51 for the year-earlier quarter; adjusted fourth-quarter EPS of $0.64 versus $0.71
>Fourth-quarter EPS reflects the success of AT&T's iPhone 3G launch. Adjusted results exclude merger-related costs and a previously announced force reduction charge. In addition, both reported and adjusted fourth-quarter 2008 earnings include $0.07 of pressure from the company's iPhone 3G initiative, hurricane-related expenses and foreign exchange impacts
>2.1 million fourth-quarter net gain in wireless subscribers to reach 77.0 million in service, up 7.0 million over the past year
>4.3 million iPhone 3G devices activated in the second half of 2008, including 1.9 million in the fourth quarter. Approximately 40 percent of iPhone activations were for customers new to AT&T. iPhone 3G continues to deliver high-value subscribers with significantly higher ARPU (average monthly revenues per subscriber) and lower churn than AT&T's postpaid subscriber average
>Wireless postpaid subscriber ARPU growth of 3.9 percent versus the year-earlier quarter to $59.59; postpaid data ARPU up 35.7 percent versus the fourth quarter of 2007 and up 10.9 percent sequentially
>51.2 percent growth in wireless data revenues — reflecting rapid adoption of wireless integrated devices and increased usage of wireless Internet access, messaging and related services; AT&T's wireless integrated devices in service more than doubled over the past year
>Strong ramp in AT&T U-verseSM TV subscribers, with a fourth-quarter net increase of 264,000, the company's best quarterly gain to date, to reach more than 1 million in service; U-verse network deployment now reaches 17 million living units
>14.2 percent fourth-quarter growth in wireline IP data revenues driven by rapid expansion in AT&T U-verse services and growth in business products such as Virtual Private Networks (VPNs) and managed Internet services
GM, Ford, Chrysler Cut Jobs Bank
The UAW has agreed to suspend the Jobs Bank program and allow the Detroit 3 to delay making payments to a retiree health care trust in 2010 to help the automakers through their cash crisis, UAW President Ron Gettelfinger said. Gettelfinger spoke after summoning the presidents and chairmen from Detroit 3 locals for an emergency meeting in Detroit today. The union is willing to make modifications to the 2007 contracts reached with General Motors, Ford Motor Co. and Chrysler LLC, said Jeff Everett, a local Chrysler president who attended the meeting. He said concessions on wages and benefits for active workers weren’t discussed. “Times are tough, and we are going to do what we have to do,’’ said Everett, president of UAW Local 1166 in Kokomo, Ind., in an interview. Under the so-called Jobs Bank program, laid-off factory workers can receive as much as 95 percent of their regular pay. The payouts have drawn scorn from opponents of federal aid who see them as a sign of Detroit’s excess.
Possible Downgrade For GE
FAIRFIELD, Conn.--(BUSINESS WIRE)
Moody’s informed us today it has placed General Electric Company's and General Electric Capital Corporation's (GECC) long-term Aaa ratings on review for possible downgrade. This review does not affect GE’s and GECC’s short-term funding ratings of Prime-1 (P-1), which were affirmed by Moody's. This action is a follow-up to Moody’s December review of GE’s 2009 operating plan. GE has outlined a plan for the year that is based on the difficult global economic environment we see. During the next few months, we will work constructively with Moody’s on its review. Our objective is to maintain our Triple-A rating but we do not anticipate any major operational impacts should that change. We expect to deliver on the 2009 financial framework that we outlined last week.
Moody’s informed us today it has placed General Electric Company's and General Electric Capital Corporation's (GECC) long-term Aaa ratings on review for possible downgrade. This review does not affect GE’s and GECC’s short-term funding ratings of Prime-1 (P-1), which were affirmed by Moody's. This action is a follow-up to Moody’s December review of GE’s 2009 operating plan. GE has outlined a plan for the year that is based on the difficult global economic environment we see. During the next few months, we will work constructively with Moody’s on its review. Our objective is to maintain our Triple-A rating but we do not anticipate any major operational impacts should that change. We expect to deliver on the 2009 financial framework that we outlined last week.
Friday, January 23, 2009
GE 4th Quarter 2008 Earnings Inline
GE Earned $18.1B in ‘08;
4Q ‘08 Results in Line with December Outlook;
Industrial CFOA of $16.7B up 5%;
Cash on Balance Sheet Grew from $16B in 3Q to $48B at YE;
No Change to Plan for $1.24 Dividend, ‘09 Framework,
and Running Company to be Triple-A
Fairfield, Conn., Jan. 23, 2009 – GE announced today fourth-quarter 2008 earnings from continuing operations of $3.9 billion, or $.37 per share before preferred dividend, or $.36 per share attributable to common shareowners. Results included $1.5 billion of after-tax restructuring and other charges, including increased reserves in current environment, which are above the Company’s original plan and the restructuring will lower costs for 2009 and beyond.
4Q and FY 2008 Highlights (Continuing Operations)
4Q earnings per share (EPS) of $.37 before preferred dividend (including charges), or $.36 attributable to common shareowners (including charges); 4Q earnings of $3.9 billion
Full-year (FY) EPS of $1.79 before preferred dividend, or $1.78 attributable to common shareowners; FY earnings of $18.1 billion
Infrastructure and Media earnings up 3% in 4Q and 10% for year
Capital Finance earned $1 billion in 4Q and $8.6 billion for year
4Q revenues of $46.2 billion, impacted by stronger U.S. dollar and business exits; FY revenues of $183 billion, up 6%; FY Industrial organic revenue growth of 8%; global revenue growth of 13%
Recorded $1.5 billion of restructuring, including increased reserves in current environment, versus guidance of up to $1.4 billion
Through today, achieved 64% of 2009 long-term debt goal; commercial paper of $72 billion at yearend, a decrease of $29 billion year-over-year
Infrastructure 4Q orders declined 6%; Total equipment and services backlog grew to $172 billion, up 9%
Fairfield, Conn., Jan. 23, 2009 – GE announced today fourth-quarter 2008 earnings from continuing operations of $3.9 billion, or $.37 per share before preferred dividend, or $.36 per share attributable to common shareowners. Results included $1.5 billion of after-tax restructuring and other charges, including increased reserves in current environment, which are above the Company’s original plan and the restructuring will lower costs for 2009 and beyond.
For the year, revenue was $183 billion, up 6%, and earnings were $18.1 billion, down 19%. This was the third highest earnings year in GE history.
“In a very tough environment, we delivered fourth quarter business results in line with expectations we provided in December,” Chairman and CEO Jeff Immelt said. “We grew Infrastructure and Media by 3% in the quarter and 10% for the year. Energy Infrastructure led the way in the quarter with 11% segment profit growth driven by continued global demand. Technology Infrastructure grew earnings by 1%, led by 21% growth in Aviation. NBC Universal segment profits declined 6% in fourth quarter as strong cable earnings were offset by declines in the local stations.
“Capital Finance earned $1 billion in the quarter and $8.6 billion for the year,” Immelt said. “We had several negative impacts to earnings in the quarter including increased loss reserves, negative marks and impairments. These charges, along with global benefits, generated a tax credit that more than offset our pre-tax loss. We also originated $48 billion of new assets in the quarter at solid margins. “We run the company to have a Triple-A credit rating, and we have significantly strengthened our liquidity position,” Immelt said. “We generated $16.7 billion of industrial cash flow from operations, up 5%. We ended the year with $48 billion in total cash, after paying down our commercial paper balance to $72 billion from $88 billion at the third quarter. We used $5.5 billion of our equity offering to meet our stated GE Capital debt-to-equity leverage goal of 7:1 by the end of 2008. Through today, we have been able to fund $29 billion of our $45 billion long-term debt needs for 2009. “The first quarter dividend is done, and we are committed to our plan for $1.24 per share for the year. We believe the GE dividend provides our investors with a solid return in this uncertain time,” Immelt said.
4Q ‘08 Results in Line with December Outlook;
Industrial CFOA of $16.7B up 5%;
Cash on Balance Sheet Grew from $16B in 3Q to $48B at YE;
No Change to Plan for $1.24 Dividend, ‘09 Framework,
and Running Company to be Triple-A
Fairfield, Conn., Jan. 23, 2009 – GE announced today fourth-quarter 2008 earnings from continuing operations of $3.9 billion, or $.37 per share before preferred dividend, or $.36 per share attributable to common shareowners. Results included $1.5 billion of after-tax restructuring and other charges, including increased reserves in current environment, which are above the Company’s original plan and the restructuring will lower costs for 2009 and beyond.
4Q and FY 2008 Highlights (Continuing Operations)
4Q earnings per share (EPS) of $.37 before preferred dividend (including charges), or $.36 attributable to common shareowners (including charges); 4Q earnings of $3.9 billion
Full-year (FY) EPS of $1.79 before preferred dividend, or $1.78 attributable to common shareowners; FY earnings of $18.1 billion
Infrastructure and Media earnings up 3% in 4Q and 10% for year
Capital Finance earned $1 billion in 4Q and $8.6 billion for year
4Q revenues of $46.2 billion, impacted by stronger U.S. dollar and business exits; FY revenues of $183 billion, up 6%; FY Industrial organic revenue growth of 8%; global revenue growth of 13%
Recorded $1.5 billion of restructuring, including increased reserves in current environment, versus guidance of up to $1.4 billion
Through today, achieved 64% of 2009 long-term debt goal; commercial paper of $72 billion at yearend, a decrease of $29 billion year-over-year
Infrastructure 4Q orders declined 6%; Total equipment and services backlog grew to $172 billion, up 9%
Fairfield, Conn., Jan. 23, 2009 – GE announced today fourth-quarter 2008 earnings from continuing operations of $3.9 billion, or $.37 per share before preferred dividend, or $.36 per share attributable to common shareowners. Results included $1.5 billion of after-tax restructuring and other charges, including increased reserves in current environment, which are above the Company’s original plan and the restructuring will lower costs for 2009 and beyond.
For the year, revenue was $183 billion, up 6%, and earnings were $18.1 billion, down 19%. This was the third highest earnings year in GE history.
“In a very tough environment, we delivered fourth quarter business results in line with expectations we provided in December,” Chairman and CEO Jeff Immelt said. “We grew Infrastructure and Media by 3% in the quarter and 10% for the year. Energy Infrastructure led the way in the quarter with 11% segment profit growth driven by continued global demand. Technology Infrastructure grew earnings by 1%, led by 21% growth in Aviation. NBC Universal segment profits declined 6% in fourth quarter as strong cable earnings were offset by declines in the local stations.
“Capital Finance earned $1 billion in the quarter and $8.6 billion for the year,” Immelt said. “We had several negative impacts to earnings in the quarter including increased loss reserves, negative marks and impairments. These charges, along with global benefits, generated a tax credit that more than offset our pre-tax loss. We also originated $48 billion of new assets in the quarter at solid margins. “We run the company to have a Triple-A credit rating, and we have significantly strengthened our liquidity position,” Immelt said. “We generated $16.7 billion of industrial cash flow from operations, up 5%. We ended the year with $48 billion in total cash, after paying down our commercial paper balance to $72 billion from $88 billion at the third quarter. We used $5.5 billion of our equity offering to meet our stated GE Capital debt-to-equity leverage goal of 7:1 by the end of 2008. Through today, we have been able to fund $29 billion of our $45 billion long-term debt needs for 2009. “The first quarter dividend is done, and we are committed to our plan for $1.24 per share for the year. We believe the GE dividend provides our investors with a solid return in this uncertain time,” Immelt said.
Monday, January 5, 2009
AT&T U-Verse
AT&T Inc. (NYSE:T) today announced that AT&T U-verseSM TV has reached its 1 millionth customer. The subscriber milestone comes less than two and a half years after AT&T Mobility and Consumer Markets introduced the only 100-percent Internet Protocol (IP) TV service offered by a national service provider.
IP technology enables state of the art features and functionality, and integration across TV, broadband, wireless and home phone services. Since its market introduction, U-verse TV has received industry acclaim for customer satisfaction, service excellence and innovation. AT&T U-verse TV ranked "Highest in Residential Television Service Satisfaction in the North Central, South, and West Regions," according to the J.D. Power and Associates 2008 Residential Television Service Provider Satisfaction StudySM. Industry analyst group Frost & Sullivan named AT&T U-verse the 2009 North American Consumer Communications Service Product of the Year, and U-verse Total Home DVR was recognized with a 2008 TelcoTV Vision Award for Service Provider Innovation.
AT&T U-verse TV has been deployed in 79 major markets across 16 states, where policy makers have enacted forward-looking policy through legislation, municipal support and other decisions to encourage investment and competition by streamlining the process for providers to enter the video marketplace. The deployment of AT&T U-verse is rapidly introducing competitive choice and next-generation services to more consumers.
"Reaching this milestone, in this short time period, further validates our video strategy and shows that we're providing customers with a better choice and a better experience than cable," said Ralph de la Vega, chief executive officer of AT&T Mobility and Consumer Markets. "We're using our all-IP U-verse platform and our wireless assets to give customers what they want, in a way that no one else can."
AT&T U-verse customers enjoy quadruple-play integration, enhanced features and greater value, all made possible by IP technology. IP technology allows AT&T U-verse to easily and constantly evolve with new features and services to match consumer needs. In 2008, AT&T Mobility and Consumer Markets introduced several U-verse TV enhancements to its subscriber base that helped customer growth and satisfaction. The list of differentiating U-verse TV features includes:
Total Home DVR, which lets you watch recorded High Definition (HD) and Standard Definition shows from a single DVR on any connected TV in the home.
An extensive lineup, including more than 85 HD channels and several international channels.
The ability to record up to four programs at once and schedule recordings from a PC or wireless device.
YELLOWPAGES.COM TV, for fast and easy searches to find local businesses and other information via your TV screen.
AT&T U-bar, which brings customizable weather, stock, sports and traffic information to the U-verse TV screen, without interrupting the current program.
AT&T Online Photos from Flickr, which allows AT&T High Speed Internet customers to browse the photos you've uploaded to flickr.com and watch slide shows on your U-verse TV screen from the comfort of your couch.
Yahoo! Sports Fantasy Football, which allows you to track the progress of your fantasy team — including current team matchups and league standings — directly from your TV screen through the AT&T U-bar.
AT&T Yahoo! Games, so you can play your favorite online games — including Sudoku, Solitaire, JT's Blocks, Mah-jongg Tiles and Chess — on the TV screen.
Built-in Picture-in-Picture, which lets you channel-surf on any television without leaving the program you're watching.
Fast channel changing, reducing the delay experienced with other digital video services.
An expanded Video On Demand (VOD) library, including HD VOD titles and more than 1,000 full-length movies.
The ability to watch and record up to two HD programs at once.
IP technology enables state of the art features and functionality, and integration across TV, broadband, wireless and home phone services. Since its market introduction, U-verse TV has received industry acclaim for customer satisfaction, service excellence and innovation. AT&T U-verse TV ranked "Highest in Residential Television Service Satisfaction in the North Central, South, and West Regions," according to the J.D. Power and Associates 2008 Residential Television Service Provider Satisfaction StudySM. Industry analyst group Frost & Sullivan named AT&T U-verse the 2009 North American Consumer Communications Service Product of the Year, and U-verse Total Home DVR was recognized with a 2008 TelcoTV Vision Award for Service Provider Innovation.
AT&T U-verse TV has been deployed in 79 major markets across 16 states, where policy makers have enacted forward-looking policy through legislation, municipal support and other decisions to encourage investment and competition by streamlining the process for providers to enter the video marketplace. The deployment of AT&T U-verse is rapidly introducing competitive choice and next-generation services to more consumers.
"Reaching this milestone, in this short time period, further validates our video strategy and shows that we're providing customers with a better choice and a better experience than cable," said Ralph de la Vega, chief executive officer of AT&T Mobility and Consumer Markets. "We're using our all-IP U-verse platform and our wireless assets to give customers what they want, in a way that no one else can."
AT&T U-verse customers enjoy quadruple-play integration, enhanced features and greater value, all made possible by IP technology. IP technology allows AT&T U-verse to easily and constantly evolve with new features and services to match consumer needs. In 2008, AT&T Mobility and Consumer Markets introduced several U-verse TV enhancements to its subscriber base that helped customer growth and satisfaction. The list of differentiating U-verse TV features includes:
Total Home DVR, which lets you watch recorded High Definition (HD) and Standard Definition shows from a single DVR on any connected TV in the home.
An extensive lineup, including more than 85 HD channels and several international channels.
The ability to record up to four programs at once and schedule recordings from a PC or wireless device.
YELLOWPAGES.COM TV, for fast and easy searches to find local businesses and other information via your TV screen.
AT&T U-bar, which brings customizable weather, stock, sports and traffic information to the U-verse TV screen, without interrupting the current program.
AT&T Online Photos from Flickr, which allows AT&T High Speed Internet customers to browse the photos you've uploaded to flickr.com and watch slide shows on your U-verse TV screen from the comfort of your couch.
Yahoo! Sports Fantasy Football, which allows you to track the progress of your fantasy team — including current team matchups and league standings — directly from your TV screen through the AT&T U-bar.
AT&T Yahoo! Games, so you can play your favorite online games — including Sudoku, Solitaire, JT's Blocks, Mah-jongg Tiles and Chess — on the TV screen.
Built-in Picture-in-Picture, which lets you channel-surf on any television without leaving the program you're watching.
Fast channel changing, reducing the delay experienced with other digital video services.
An expanded Video On Demand (VOD) library, including HD VOD titles and more than 1,000 full-length movies.
The ability to watch and record up to two HD programs at once.
GE Collaborates With Turkey

GE Transportation and Tülomsaş Combine Expertise To Supply Markets with GE’s PowerHaul™ Series Locomotives
GE Transportation, a unit of General Electric Company (NYSE: GE), and Tülomsaş have announced the signing of a Memorandum of Understanding (MOU) for a strategic relationship in which GE Transportation and Tülomsaş have agreed to collaborate to supply the market with GE’s PowerHaul™ locomotives.
Under the terms of the agreement, GE will supply Tülomsaş with the necessary technology and material to assemble GE’s PowerHaul series locomotives in Turkey for the European, Middle East and North African markets. "Our strategic approach is to bring to the market advanced technology from GE, a world leader in diesel electric locomotives, with Tülomsaş’s manufacturing expertise, while remaining a productive, profitable and competitive enterprise,” said Hayri Avci, General Director and Chairman of Board of Directors of Tülomsaş,. “Our strategic relationship with GE will be beneficial to both companies and help Tülomsaş expand its footprint and increase its technological prowess and profitability. This relationship brings two companies together, each of which has over 100 years of locomotive manufacturing experience.” “GE Transportation is committed to growth by focusing on technical leadership, deep enduring customer relationships and global competitiveness,” said Lorenzo Simonelli, President and CEO of GE Transportation. “We are very pleased to be working with Tülomsaş on this MOU as it is a natural step along the path to regional localization of our capabilities.” Added Simonelli: “We're investing in Turkey because of its strategic proximity to the customers we wish to serve and its advanced technology and manufacturing skills. Finally, we hope to leverage GE’s longstanding expertise and global reach to be a true partner in the economic development of the country. “ GE’s PowerHaul series locomotives are driven by the 16-cylinder PowerHaul engine, which is GE’s most technologically advanced locomotive engine to-date. This new engine combined with other technologies from GE is projected to reduce PowerHaul Locomotive fuel use by up to 9% compared to current operating fleet averages. The 3,700 GHP engine is European Stage IIIa compliant and Ecomagination certified. Ecomagination is a GE-wide commitment to developing technology designed to help GE customers satisfy environmental challenges, while maximizing performance and reducing cost. GE Transportation’s PowerHaul Locomotive is based on the company’s global Evolution® Series locomotive platform introduced in 2005. With close to 3,000 units in use today, the Evolution Series locomotive is one of GE Transportation’s best-selling products worldwide. “The PowerHaul engine used in these locomotives significantly increases fuel efficiency while lowering emissions, said Simonelli. “PowerHaul Locomotives are designed for cost-effective long-haul operating range, high pulling power, long-term emissions compliance and reduced life-cycle cost.” GE Transportation received an order for 30 locomotives, powered by GE’s PowerHaul engine, from UK-based Freightliner Group Ltd. in November 2007. The purchase represented the largest order of freight locomotives in Freightliner’s history and the PowerHaul engine’s debut into the UK and European market place. More than 16,500 GE locomotives are currently in use in more than 50 countries around the world. GE Transportation has evolved from a supplier to the North American rail industry to a global transportation leader. Through the end of 2008, international locomotive orders will contribute more than 40% of the company’s locomotive-related revenue.
GE Transportation, a unit of General Electric Company (NYSE: GE), and Tülomsaş have announced the signing of a Memorandum of Understanding (MOU) for a strategic relationship in which GE Transportation and Tülomsaş have agreed to collaborate to supply the market with GE’s PowerHaul™ locomotives.
Under the terms of the agreement, GE will supply Tülomsaş with the necessary technology and material to assemble GE’s PowerHaul series locomotives in Turkey for the European, Middle East and North African markets. "Our strategic approach is to bring to the market advanced technology from GE, a world leader in diesel electric locomotives, with Tülomsaş’s manufacturing expertise, while remaining a productive, profitable and competitive enterprise,” said Hayri Avci, General Director and Chairman of Board of Directors of Tülomsaş,. “Our strategic relationship with GE will be beneficial to both companies and help Tülomsaş expand its footprint and increase its technological prowess and profitability. This relationship brings two companies together, each of which has over 100 years of locomotive manufacturing experience.” “GE Transportation is committed to growth by focusing on technical leadership, deep enduring customer relationships and global competitiveness,” said Lorenzo Simonelli, President and CEO of GE Transportation. “We are very pleased to be working with Tülomsaş on this MOU as it is a natural step along the path to regional localization of our capabilities.” Added Simonelli: “We're investing in Turkey because of its strategic proximity to the customers we wish to serve and its advanced technology and manufacturing skills. Finally, we hope to leverage GE’s longstanding expertise and global reach to be a true partner in the economic development of the country. “ GE’s PowerHaul series locomotives are driven by the 16-cylinder PowerHaul engine, which is GE’s most technologically advanced locomotive engine to-date. This new engine combined with other technologies from GE is projected to reduce PowerHaul Locomotive fuel use by up to 9% compared to current operating fleet averages. The 3,700 GHP engine is European Stage IIIa compliant and Ecomagination certified. Ecomagination is a GE-wide commitment to developing technology designed to help GE customers satisfy environmental challenges, while maximizing performance and reducing cost. GE Transportation’s PowerHaul Locomotive is based on the company’s global Evolution® Series locomotive platform introduced in 2005. With close to 3,000 units in use today, the Evolution Series locomotive is one of GE Transportation’s best-selling products worldwide. “The PowerHaul engine used in these locomotives significantly increases fuel efficiency while lowering emissions, said Simonelli. “PowerHaul Locomotives are designed for cost-effective long-haul operating range, high pulling power, long-term emissions compliance and reduced life-cycle cost.” GE Transportation received an order for 30 locomotives, powered by GE’s PowerHaul engine, from UK-based Freightliner Group Ltd. in November 2007. The purchase represented the largest order of freight locomotives in Freightliner’s history and the PowerHaul engine’s debut into the UK and European market place. More than 16,500 GE locomotives are currently in use in more than 50 countries around the world. GE Transportation has evolved from a supplier to the North American rail industry to a global transportation leader. Through the end of 2008, international locomotive orders will contribute more than 40% of the company’s locomotive-related revenue.
Friday, January 2, 2009
Aetna To Underwrite Pets Best Insurance
Pets Best Announces New Underwriter For Pet Insurance Policies
BOISE, Idaho, December 16, 2008 — Pets Best Insurance LLC (Pets Best) announced today that effective December 12, 2008, new policies will be underwritten by Aetna Insurance Company of Connecticut (AICC) in Alabama, District of Columbia, Idaho, Iowa, Montana, North Dakota and Texas. The change will strengthen Pets Best's overall position in the industry and provide a better platform for the continued growth of its mission to protect pets throughout the U.S. Existing policy holders will be automatically notified when policies roll over to AICC-underwritten coverage.
"This will be a seamless transition for our existing customers and will allow us to provide more options for pet owners, including increased coverage and additional deductible levels," said Jack Stephens DVM, President of Pets Best Insurance. "In these uncertain economic times, we want pet owners to know that they don't have to deal with pet accidents and illnesses alone. Now more than ever, we want people to know about their options for protection."
Pets Best plans will remain competitively priced, with reimbursements based on a straightforward 80 percent of veterinary bills after the deductible. Premium rates with AICC will be based on experience by breed, pet age and the typical veterinary costs within each policy holder's local area.
Pets Best and AICC will work together to extend outreach to pet owners, communicating the value of budgeting for unexpected accidents and illness through reliable, affordable insurance. Plans will include a choice of higher deductibles for pet owners who want to lower the cost of their premiums. The expanded range of options will give policyholders the ability to design plans around their budget and risk tolerance.
Importantly, Pets Best plans underwritten by AICC have earned the exclusive recommendation of the American Veterinary Medical Association Group Health and Life Insurance Trust (AVMA GHLIT). "The veterinary profession is a trusted source of information and education for pet owners. Increasing awareness and usage of pet insurance will increase the overall health of pets by providing an additional financial resource so that needed care can be affordably delivered," said Gary R. Holfinger DVM, Chairman of the Board of Trustees of the AVMA GHLIT."As the new underwriter for Pets Best policies, we look forward to working closely with Pets Best and the AVMA GHLIT to extend the reach of the pet insurance industry to bring trusted, affordable pet health insurance products to pet owners nationwide," said Gretchen Spann, Aetna's head of pet insurance.
About Pets Best Insurance
Pets Best Insurance administers an insurance plan that reimburses pet owners for a straightforward 80 percent of veterinary services after a deductible, with no benefit schedules or fee restrictions. Pets Best plans do not include age restrictions and allow the pet owner to choose their veterinarian. Any pet can have guaranteed acceptance for accident-only policies so that even seriously ill pets can be insured against unexpected costs from accidental injury. The Pets Best Insurance team is a group of pet lovers who strive to deliver quality customer service and value. As the creator of the oldest and largest pet insurer in the United States, Jack Stephens DVM is the pioneer of pet health insurance and brings 26 years of experience in helping pet owners afford quality care for their pets. Insurance plans offered and administered by Pets Best are underwritten by Aetna Insurance Company of Connecticut (AICC) and recommended by the American Veterinary Medical Association Group Health and Life Insurance Trust (AVMA GHLIT). Visit Pets Best Insurance at petsbest.com or phone 877-PetsBest (738-7237).
BOISE, Idaho, December 16, 2008 — Pets Best Insurance LLC (Pets Best) announced today that effective December 12, 2008, new policies will be underwritten by Aetna Insurance Company of Connecticut (AICC) in Alabama, District of Columbia, Idaho, Iowa, Montana, North Dakota and Texas. The change will strengthen Pets Best's overall position in the industry and provide a better platform for the continued growth of its mission to protect pets throughout the U.S. Existing policy holders will be automatically notified when policies roll over to AICC-underwritten coverage.
"This will be a seamless transition for our existing customers and will allow us to provide more options for pet owners, including increased coverage and additional deductible levels," said Jack Stephens DVM, President of Pets Best Insurance. "In these uncertain economic times, we want pet owners to know that they don't have to deal with pet accidents and illnesses alone. Now more than ever, we want people to know about their options for protection."
Pets Best plans will remain competitively priced, with reimbursements based on a straightforward 80 percent of veterinary bills after the deductible. Premium rates with AICC will be based on experience by breed, pet age and the typical veterinary costs within each policy holder's local area.
Pets Best and AICC will work together to extend outreach to pet owners, communicating the value of budgeting for unexpected accidents and illness through reliable, affordable insurance. Plans will include a choice of higher deductibles for pet owners who want to lower the cost of their premiums. The expanded range of options will give policyholders the ability to design plans around their budget and risk tolerance.
Importantly, Pets Best plans underwritten by AICC have earned the exclusive recommendation of the American Veterinary Medical Association Group Health and Life Insurance Trust (AVMA GHLIT). "The veterinary profession is a trusted source of information and education for pet owners. Increasing awareness and usage of pet insurance will increase the overall health of pets by providing an additional financial resource so that needed care can be affordably delivered," said Gary R. Holfinger DVM, Chairman of the Board of Trustees of the AVMA GHLIT."As the new underwriter for Pets Best policies, we look forward to working closely with Pets Best and the AVMA GHLIT to extend the reach of the pet insurance industry to bring trusted, affordable pet health insurance products to pet owners nationwide," said Gretchen Spann, Aetna's head of pet insurance.
About Pets Best Insurance
Pets Best Insurance administers an insurance plan that reimburses pet owners for a straightforward 80 percent of veterinary services after a deductible, with no benefit schedules or fee restrictions. Pets Best plans do not include age restrictions and allow the pet owner to choose their veterinarian. Any pet can have guaranteed acceptance for accident-only policies so that even seriously ill pets can be insured against unexpected costs from accidental injury. The Pets Best Insurance team is a group of pet lovers who strive to deliver quality customer service and value. As the creator of the oldest and largest pet insurer in the United States, Jack Stephens DVM is the pioneer of pet health insurance and brings 26 years of experience in helping pet owners afford quality care for their pets. Insurance plans offered and administered by Pets Best are underwritten by Aetna Insurance Company of Connecticut (AICC) and recommended by the American Veterinary Medical Association Group Health and Life Insurance Trust (AVMA GHLIT). Visit Pets Best Insurance at petsbest.com or phone 877-PetsBest (738-7237).
Merck's Long-Term Outlook
Merck Outlines Long-Term Prospects and Progress on Strategic Plan at 2008 Annual Business Briefing
>Company Expects to File New Drug Applications With the FDA for Telcagepant, Rolofylline and Ezetimibe/Atorvastatin; Will Seek Approval of New Indications for GARDASIL and ISENTRESS in 2009
>Merck's Pipeline Continues to Progress with Six New Phase III Development Programs Anticipated to Start in 2009 and Seven Phase III Programs Continuing
>Merck Plans Three Phase III Programs for New Indications to Start in 2009 and Two Phase III Programs for New Indications Continuing in 2009
>JANUVIA, JANUMET and ISENTRESS Expected to Deliver Strong Growth as Worldwide Launches Continue
>Implementation of New Business Models Continue in U.S., Europe and Japan; Company Expanding Business in Emerging Markets
>Company Forms Merck BioVentures Division for Follow-on Biologics
Merck's Late-Stage Pipeline Advances
Peter S. Kim, Ph.D., executive vice president and president, Merck Research Laboratories, told analysts that in 2009, the Company anticipates submitting three New Drug Application (NDA) filings with the U.S. Food and Drug Administration (FDA): MK-0974, telcagepant, an investigational compound for the treatment of migraines; MK-7418, rolofylline, an investigational compound for the treatment of acute heart failure; and MK-0653C, ezetimibe combined with atorvastatin, an investigational medication for the treatment of dyslipidemia being developed by the Merck-Schering Plough joint venture.
The Company also anticipates regulatory action in 2009 on three supplemental filings that have been or will be submitted to the FDA and other regulatory agencies: two for GARDASIL, Merck's HPV vaccine, for an expanded indication for adult women through age 45 and for use in males; and one for ISENTRESS, a first-in-class integrase inhibitor for the treatment of HIV-1 infection, for an expanded indication for use in treatment-naïve patients. In the U.S. alone, if approved, the treatment-naïve indication would triple the number of patients for whom ISENTRESS would be indicated.
At the briefing, Dr. Kim profiled the Company's extensive and diverse research and development efforts that include 47 active clinical programs across the Company's major research franchises: bone, respiratory, immunology and endocrine; cardiovascular; diabetes and obesity; infectious diseases; neuroscience; oncology and vaccines.
Dr. Kim told analysts that as of Dec. 9, 2008, Merck's pipeline includes nine candidates in Phase III, 15 in Phase II and 23 in Phase I. And he detailed seven of the drug candidates currently in Phase III clinical development:
MK-7418, rolofylline, a potential first-in-class selective adenosine A1 antagonist, is a Phase III investigational drug being evaluated for the treatment of acute heart failure. An NDA filing with the FDA continues to be anticipated in 2009.
MK-0974, telcagepant, an investigational oral calcitonin gene-related peptide receptor antagonist, represents a new mechanism for the treatment of migraine and has demonstrated efficacy comparable to zolmitriptan, an effective triptan, in the Phase III clinical program. The Company continues to anticipate filing an NDA with the FDA in 2009.
MK-8669, deforolimus, is a novel mTor (mammalian target of rapamycin) inhibitor being evaluated for the treatment of cancer. The drug candidate is being jointly developed and commercialized with ARIAD Pharmaceuticals, Inc., under an agreement reached in 2007. A Phase III study (SUCCEED) in patients with metastatic soft-tissue or bone sarcomas is under way. The Company continues to anticipate filing an NDA with the FDA in 2010.
V503, a nine-valent HPV vaccine in development to provide broader coverage against HPV. The Phase III clinical program is underway and Merck anticipates a filing with the FDA in 2012.
MK-0822, odanacatib, is a highly selective inhibitor of the cathepsin K enzyme, which is being evaluated for the treatment of osteoporosis. The Phase III program is ongoing. Merck said that it continues to anticipate filing an NDA with the FDA in 2012.
MK-0524A is a drug candidate that combines extended-release niacin and a novel flushing inhibitor, laropiprant. MK-0524A has demonstrated the ability to lower LDL-cholesterol (LDL-C), raise HDL-cholesterol (HDL-C) and lower triglycerides with significantly less flushing than traditional extended release niacin alone. The cardiovascular outcomes trial, HPS2-THRIVE, is ongoing and expected to complete in 2012. Merck anticipates filing an NDA with the FDA for MK-0524A in 2012.
MK-0859, anacetrapib, is an inhibitor of the cholesteryl ester transfer protein (CETP) that has shown promise in lipid management by raising HDL-C and reducing LDL-C without raising blood pressure. A Phase III study was initiated in April 2008 and enrollment in a cardiovascular outcomes study is expected to begin in 2010. The Company anticipates filing an NDA with the FDA beyond 2014.
Additionally, Dr. Kim detailed the six potential 2009 Phase III candidates, notably:
V710, a novel Staphylococcus aureus (S. aureus) vaccine that targets a highly conserved antigen originally discovered by Intercell AG. A Phase II/III sequential design study in cardiothoracic surgery patients at acute risk of infection is underway and additional studies are under consideration. S. aureus infections are a major public health challenge and represent a serious unmet medical need. Merck anticipates a filing with the FDA in 2011.
MK-0633, a once-daily 5-Lipoxygenase (5-LO) inhibitor that has the potential to decrease the production of all leukotrienes, key mediators of inflammation. MK-0633 is currently being evaluated in a Phase IIb study for the treatment of asthma and a Phase IIa study for the treatment of chronic obstructive pulmonary disease (COPD). The Company anticipates filing MK-0633 for asthma in 2011.
>Company Expects to File New Drug Applications With the FDA for Telcagepant, Rolofylline and Ezetimibe/Atorvastatin; Will Seek Approval of New Indications for GARDASIL and ISENTRESS in 2009
>Merck's Pipeline Continues to Progress with Six New Phase III Development Programs Anticipated to Start in 2009 and Seven Phase III Programs Continuing
>Merck Plans Three Phase III Programs for New Indications to Start in 2009 and Two Phase III Programs for New Indications Continuing in 2009
>JANUVIA, JANUMET and ISENTRESS Expected to Deliver Strong Growth as Worldwide Launches Continue
>Implementation of New Business Models Continue in U.S., Europe and Japan; Company Expanding Business in Emerging Markets
>Company Forms Merck BioVentures Division for Follow-on Biologics
Merck's Late-Stage Pipeline Advances
Peter S. Kim, Ph.D., executive vice president and president, Merck Research Laboratories, told analysts that in 2009, the Company anticipates submitting three New Drug Application (NDA) filings with the U.S. Food and Drug Administration (FDA): MK-0974, telcagepant, an investigational compound for the treatment of migraines; MK-7418, rolofylline, an investigational compound for the treatment of acute heart failure; and MK-0653C, ezetimibe combined with atorvastatin, an investigational medication for the treatment of dyslipidemia being developed by the Merck-Schering Plough joint venture.
The Company also anticipates regulatory action in 2009 on three supplemental filings that have been or will be submitted to the FDA and other regulatory agencies: two for GARDASIL, Merck's HPV vaccine, for an expanded indication for adult women through age 45 and for use in males; and one for ISENTRESS, a first-in-class integrase inhibitor for the treatment of HIV-1 infection, for an expanded indication for use in treatment-naïve patients. In the U.S. alone, if approved, the treatment-naïve indication would triple the number of patients for whom ISENTRESS would be indicated.
At the briefing, Dr. Kim profiled the Company's extensive and diverse research and development efforts that include 47 active clinical programs across the Company's major research franchises: bone, respiratory, immunology and endocrine; cardiovascular; diabetes and obesity; infectious diseases; neuroscience; oncology and vaccines.
Dr. Kim told analysts that as of Dec. 9, 2008, Merck's pipeline includes nine candidates in Phase III, 15 in Phase II and 23 in Phase I. And he detailed seven of the drug candidates currently in Phase III clinical development:
MK-7418, rolofylline, a potential first-in-class selective adenosine A1 antagonist, is a Phase III investigational drug being evaluated for the treatment of acute heart failure. An NDA filing with the FDA continues to be anticipated in 2009.
MK-0974, telcagepant, an investigational oral calcitonin gene-related peptide receptor antagonist, represents a new mechanism for the treatment of migraine and has demonstrated efficacy comparable to zolmitriptan, an effective triptan, in the Phase III clinical program. The Company continues to anticipate filing an NDA with the FDA in 2009.
MK-8669, deforolimus, is a novel mTor (mammalian target of rapamycin) inhibitor being evaluated for the treatment of cancer. The drug candidate is being jointly developed and commercialized with ARIAD Pharmaceuticals, Inc., under an agreement reached in 2007. A Phase III study (SUCCEED) in patients with metastatic soft-tissue or bone sarcomas is under way. The Company continues to anticipate filing an NDA with the FDA in 2010.
V503, a nine-valent HPV vaccine in development to provide broader coverage against HPV. The Phase III clinical program is underway and Merck anticipates a filing with the FDA in 2012.
MK-0822, odanacatib, is a highly selective inhibitor of the cathepsin K enzyme, which is being evaluated for the treatment of osteoporosis. The Phase III program is ongoing. Merck said that it continues to anticipate filing an NDA with the FDA in 2012.
MK-0524A is a drug candidate that combines extended-release niacin and a novel flushing inhibitor, laropiprant. MK-0524A has demonstrated the ability to lower LDL-cholesterol (LDL-C), raise HDL-cholesterol (HDL-C) and lower triglycerides with significantly less flushing than traditional extended release niacin alone. The cardiovascular outcomes trial, HPS2-THRIVE, is ongoing and expected to complete in 2012. Merck anticipates filing an NDA with the FDA for MK-0524A in 2012.
MK-0859, anacetrapib, is an inhibitor of the cholesteryl ester transfer protein (CETP) that has shown promise in lipid management by raising HDL-C and reducing LDL-C without raising blood pressure. A Phase III study was initiated in April 2008 and enrollment in a cardiovascular outcomes study is expected to begin in 2010. The Company anticipates filing an NDA with the FDA beyond 2014.
Additionally, Dr. Kim detailed the six potential 2009 Phase III candidates, notably:
V710, a novel Staphylococcus aureus (S. aureus) vaccine that targets a highly conserved antigen originally discovered by Intercell AG. A Phase II/III sequential design study in cardiothoracic surgery patients at acute risk of infection is underway and additional studies are under consideration. S. aureus infections are a major public health challenge and represent a serious unmet medical need. Merck anticipates a filing with the FDA in 2011.
MK-0633, a once-daily 5-Lipoxygenase (5-LO) inhibitor that has the potential to decrease the production of all leukotrienes, key mediators of inflammation. MK-0633 is currently being evaluated in a Phase IIb study for the treatment of asthma and a Phase IIa study for the treatment of chronic obstructive pulmonary disease (COPD). The Company anticipates filing MK-0633 for asthma in 2011.
Wednesday, December 31, 2008
GMAC Expands Financing
DETROIT (Dec. 30, 2008) -- GMAC Financial Services will immediately resume auto financing for a broader spectrum of U.S. customers as a result of expanded access to funding as a bank holding company. The company will modify its credit criteria to include retail financing for customers with a credit bureau score of 621 or above, a significant expansion of credit compared to the 700 minimum score put in place two months ago.
GMAC's application to become a bank holding company was approved by the Federal Reserve Board of Governors on Dec. 24, 2008. The company also announced that it received an investment from the U.S. Treasury Department as part of the Troubled Assets Relief Program.
"The actions of the federal government to support GMAC are having an immediate and meaningful effect on our ability to provide credit to automotive customers," said GMAC President Bill Muir. "We will continue to employ responsible credit standards, but will be able to relax the constraints we put in place a few months ago due to the credit crisis. We will immediately put our renewed access to capital to use to facilitate the purchase of cars and trucks in the U.S."
At this time, GMAC will not finance higher risk transactions characterized by a credit bureau score of 620 or below. The company will utilize both GMAC Bank and funding from other sources to resume its traditional spectrum of prime-based credit, appropriately pricing for risk and requiring down payments where necessary.
"The majority of GMAC's auto financing has been in the prime arena," Muir said. "Therefore, opening access to credit for those with CB scores of 621 or better will allow us to return to more normal levels of financing volume, and should help in efforts to stabilize the U.S. auto industry."
GMAC's expanded financing policy and improved retail financing rates will apply to both new and certified used vehicles. Dealer wholesale financing remains a priority for GMAC, and is unchanged.
GMAC's application to become a bank holding company was approved by the Federal Reserve Board of Governors on Dec. 24, 2008. The company also announced that it received an investment from the U.S. Treasury Department as part of the Troubled Assets Relief Program.
"The actions of the federal government to support GMAC are having an immediate and meaningful effect on our ability to provide credit to automotive customers," said GMAC President Bill Muir. "We will continue to employ responsible credit standards, but will be able to relax the constraints we put in place a few months ago due to the credit crisis. We will immediately put our renewed access to capital to use to facilitate the purchase of cars and trucks in the U.S."
At this time, GMAC will not finance higher risk transactions characterized by a credit bureau score of 620 or below. The company will utilize both GMAC Bank and funding from other sources to resume its traditional spectrum of prime-based credit, appropriately pricing for risk and requiring down payments where necessary.
"The majority of GMAC's auto financing has been in the prime arena," Muir said. "Therefore, opening access to credit for those with CB scores of 621 or better will allow us to return to more normal levels of financing volume, and should help in efforts to stabilize the U.S. auto industry."
GMAC's expanded financing policy and improved retail financing rates will apply to both new and certified used vehicles. Dealer wholesale financing remains a priority for GMAC, and is unchanged.
GMAC And Tarp
NEW YORK (Dec. 29, 2008) -- GMAC Financial Services today announced that it has sold $5.0 billion of GMAC's preferred membership interests and warrants to the U.S. Department of the Treasury as a participant in the Troubled Assets Relief Program established under the Emergency Economic Stabilization Act of 2008. The sale was completed today.
GMAC also announced that General Motors Corp. (GM) and an affiliate of Cerberus Capital Management contributed to GMAC the $750 million subordinated participations in the $3.5 billion senior secured credit facility, as amended, between GMAC and Residential Capital, LLC in exchange for new common equity of GMAC. In addition, GMAC announced that GM and an affiliate of Cerberus Capital Management entered into agreements to purchase $1.25 billion of new common equity. The U.S. Treasury and GM intend to enter into an agreement for the Treasury to fund GM's share of the new common equity.
GMAC also announced that the conditions to its previously announced separate private exchange offers and cash tender offers have been satisfied and that GMAC has accepted all of the validly tendered GMAC old notes and ResCap old notes. The GMAC offers and the ResCap offers are expected to settle promptly.
GMAC received approval of its bank holding company application from the U.S. Federal Reserve Board on Dec. 24, 2008. As a bank holding company, GMAC has improved access to funding to provide financing to consumers and businesses. In particular, the company intends to act quickly to resume automotive lending to a broader spectrum of customers to support the availability of credit to consumers and businesses for the purchase of automobiles.
About GMAC Financial ServicesGMAC Financial Services is a global finance company operating in and servicing North America, South America, Europe and Asia-Pacific. GMAC specializes in automotive finance, real estate finance, insurance, commercial finance and online banking. As of Dec. 31, 2007, the organization had $248 billion in assets and serviced 15 million customers. Visit the GMAC media site at http://media.gmacfs.com/ for more information.
GMAC also announced that General Motors Corp. (GM) and an affiliate of Cerberus Capital Management contributed to GMAC the $750 million subordinated participations in the $3.5 billion senior secured credit facility, as amended, between GMAC and Residential Capital, LLC in exchange for new common equity of GMAC. In addition, GMAC announced that GM and an affiliate of Cerberus Capital Management entered into agreements to purchase $1.25 billion of new common equity. The U.S. Treasury and GM intend to enter into an agreement for the Treasury to fund GM's share of the new common equity.
GMAC also announced that the conditions to its previously announced separate private exchange offers and cash tender offers have been satisfied and that GMAC has accepted all of the validly tendered GMAC old notes and ResCap old notes. The GMAC offers and the ResCap offers are expected to settle promptly.
GMAC received approval of its bank holding company application from the U.S. Federal Reserve Board on Dec. 24, 2008. As a bank holding company, GMAC has improved access to funding to provide financing to consumers and businesses. In particular, the company intends to act quickly to resume automotive lending to a broader spectrum of customers to support the availability of credit to consumers and businesses for the purchase of automobiles.
About GMAC Financial ServicesGMAC Financial Services is a global finance company operating in and servicing North America, South America, Europe and Asia-Pacific. GMAC specializes in automotive finance, real estate finance, insurance, commercial finance and online banking. As of Dec. 31, 2007, the organization had $248 billion in assets and serviced 15 million customers. Visit the GMAC media site at http://media.gmacfs.com/ for more information.
Subscribe to:
Posts (Atom)